WuXi Biologics and Sartorius Stedim Biotech, a French company that makes biologic drug manufacturing equipment, have opened a Joint Lab in Shanghai. The lab includes microscale bioreactor systems used for early stage R&D and process optimization of biologic drug candidates, providing accelerated development, optimization and rapid scale-up of cell culture processes. SSB specializes in single-use reactors, and the company has a longstanding relationship with WuXi Biologics, a division of WuXi AppTec.
